The Pipeline Center

Filter Your Results

 

News

 

A Long-Term Treatment Option for AMD?

Treatment of wet age-related macular degeneration (AMD) with anti-VEGF agents currently requires a regimen of frequent…

An interview with Carl D. Regillo, MD

Retina News

Ablate-and-Replace Gene Therapy Was Successful in Mouse Model of RP An approach to gene therapy in which a gene editi…

Opinion: Paving the Way to Accessible Treatment for All

At a recent meeting of the US Food and Drug Administration’s Cellular, Tissue, and Gene Therapies Advisory Com…

Thomas Ciulla, MD, MBA

Novel Treatment Strategies for Diabetic Eye Disease

There is no doubt that anti -- VEGF-A monotherapy has revolutionized the treatment of diabetic macular edema (DME). …

Pravin U. Dugel, MD

Retina News

NEI Award for ‘Retina in a Dish’ A team at the University of Maryland received a $90,000 award from the U…

Therapeutic Options for Uveitis

Uveitis is an inflammatory condition associated with visual impairment, blindness, and reduced quality of life. The …

Andrea Arriola López, MD, MSc, and Thomas Albini, MD

Introduction

“The world is moving so fast these days that the man who says it can’t be done is generally interrupted by s…

The 27-Gauge Revolution

The smallest commercially available instrumentation for pars plana vitrectomy (PPV) is 27 gauge.1,2 An increasing nu…

Michael A. Klufas, MD, and Jason Hsu, MD

 

This Month's Supplements

 
 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman
Editor-in-Chief
484-581-1827
kroman@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.